Abstract
A recurrent specific JAK2 V617F mutation has been reported in bcr/abl-negative chronic myeloproliferative diseases (cMPD), including polycythemia vera (PV), essential thrombocythemia (ET) and idiopathic myelofibrosis (IMF). The mutation is detectable in a variable proportion of neoplastic clones, depending on the molecular methods employed. In this study, we attempted to establish the JAK2 V617F mutation frequency in two partially overlapping cMPD patient series by two different PCR-based techniques. Using an allele-specific polymerase chain reaction assay (AS-PCR), the JAK2 V617F mutation was detected in 124/158 (78.5%) cMPD patients; in particular, 90.2, 72.1, 63.2 and 50% of PV, ET, IMF and unclassified (U)-MPD cases, respectively, showed the mutation. Employing a semiquantitative 5' fluorogenic TaqMan assay, the JAK2 V617F mutation was identified in a much larger percentage of cMPDs patients (118/127: 92.9%). Rates of mutation in PV, ET, IMF and U-MPD cases were 95.9, 85.7, 91.7 and 92.9%, respectively. Furthermore, a statistically higher percentage of JAK2 mutated alleles was detected by TaqMan assay in PV (68+/-3.5, mean value+/-SEM) and IMF (64+/-9.3) cases as compared with ET (35+/-5.4). Finally, a significant correlati...Continue Reading
References
Sep 20, 2002·Blood·James W VardimanRichard D Brunning
Mar 23, 2005·Lancet·E Joanna BaxterUNKNOWN Cancer Genome Project
Mar 29, 2005·Nature·Chloé JamesWilliam Vainchenker
Apr 20, 2005·Cancer Cell·Ross L LevineD Gary Gilliland
Apr 29, 2005·The New England Journal of Medicine·Robert KralovicsRadek C Skoda
Apr 30, 2005·Blood·David P SteensmaAyalew Tefferi
May 3, 2005·The Journal of Biological Chemistry·Runxiang ZhaoZhizhuang Joe Zhao
May 28, 2005·Blood·Amy V JonesNicholas C P Cross
Jul 13, 2005·Mayo Clinic Proceedings·Ayalew Tefferi, D Gary Gilliland
Jul 23, 2005·Blood·Jaroslav JelinekJean-Pierre J Issa
Aug 5, 2005·Leukemia·E AntonioliA M Vannucchi
Aug 6, 2005·Blood·Ross L LevineMichael W N Deininger
Aug 24, 2005·British Journal of Haematology·Terra L LashoAyalew Tefferi
Oct 4, 2005·British Journal of Haematology·Alexandra P WolanskyjAyalew Tefferi
Oct 18, 2005·British Journal of Haematology·Ayalew TefferiD Gary Gilliland
Nov 5, 2005·Leukemia·R McClureT Lasho
Nov 19, 2005·Blood·Peter J CampbellJohn T Reilly
Dec 3, 2005·Leukemia & Lymphoma·Maria E Nelson, David P Steensma
Dec 6, 2005·Lancet·Peter J CampbellUNKNOWN Australasian Leukaemia and Lymphoma Group
Dec 13, 2005·Leukemia·C JamesN Casadevall
Dec 24, 2005·Blood·Francesco PassamontiMario Cazzola
Jan 10, 2006·British Journal of Haematology·Betty CheungClaire Harrison
Jan 19, 2006·Blood·Uday PopatJosef T Prchal
Jun 10, 2006·Gastroenterology·Raj K PatelGhulam J Mufti
Jun 16, 2006·Leukemia·P SidonP Heimann
Jun 27, 2006·Clinical Chemistry·Pierre SidonHakim El Housni
Aug 26, 2006·The Journal of Molecular Diagnostics : JMD·David P Steensma
Sep 2, 2006·Blood·Xuesong XuZhizhuang Joe Zhao
Dec 8, 2006·The New England Journal of Medicine·Peter J Campbell, Anthony R Green
Jan 27, 2007·Current Opinion in Hematology·Ayalew Tefferi, James W Vardiman
Mar 24, 2007·Blood·Alessandro M VannucchiTiziano Barbui
Mar 27, 2007·The Journal of Molecular Diagnostics : JMD·Emma HammondRichard Herrmann
Apr 27, 2007·Leukemia·S GattenlohnerA Marx
May 19, 2007·American Journal of Clinical Pathology·Angela Y C TanAlexander Dobrovic
Jul 13, 2007·Leukemia·A M VannucchiUNKNOWN MPD Research Consortium